WallStreetZenWallStreetZen

NASDAQ: OCGN
Ocugen Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for OCGN

Based on 4 analysts offering 12 month price targets for Ocugen Inc.
Min Forecast
$4.50+144.57%
Avg Forecast
$5.88+219.29%
Max Forecast
$8.00+334.78%

Should I buy or sell OCGN stock?

Based on 4 analysts offering ratings for Ocugen Inc.
Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OCGN stock forecasts and price targets.

OCGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Mizuho
Bottom 24%
24
Strong BuyInitiates Coverage On$5.00+171.74%2022-08-23
HC Wainwright & Co.
Bottom 10%
10
BuyMaintains$6.00+226.09%2022-08-15
Roth Capital
Bottom 18%
18
Strong BuyReinstates$8.00+334.78%2022-06-15
Cantor Fitzgerald
Bottom 5%
5
Strong BuyInitiates Coverage On$4.50+144.57%2022-06-02

1 of 1

Forecast return on equity

Is OCGN forecast to generate an efficient return?
Company
62.63%
Industry
22.46%
Market
122.06%
OCGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OCGN forecast to generate an efficient return on assets?
Company
54.94%
Industry
13.57%
OCGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OCGN earnings per share forecast

What is OCGN's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$0.37
Avg 2 year Forecast
-$0.39
Avg 3 year Forecast
-$0.34

OCGN revenue forecast

What is OCGN's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.1M
Avg 2 year Forecast
$32.4M
Avg 3 year Forecast
$58.9M

OCGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OCGN$1.84$5.88+219.29%Strong Buy
MGTX$8.93$32.50+263.94%Strong Buy
CDXS$6.04$22.50+272.52%Strong Buy
AVTE$16.49N/AN/AHold
PRVB$4.95$16.33+229.96%Strong Buy

Ocugen Stock Forecast FAQ

Is Ocugen Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: OCGN) stock is to Strong Buy OCGN stock.

Out of 4 analysts, 3 (75%) are recommending OCGN as a Strong Buy, 1 (25%) are recommending OCGN as a Buy, 0 (0%) are recommending OCGN as a Hold, 0 (0%) are recommending OCGN as a Sell, and 0 (0%) are recommending OCGN as a Strong Sell.

If you're new to stock investing, here's how to buy Ocugen stock.

What is OCGN's earnings growth forecast for 2022-2024?

(NASDAQ: OCGN) Ocugen's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 8.86%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.88%.

Ocugen's earnings in 2022 is -$62,826,000.On average, 4 Wall Street analysts forecast OCGN's earnings for 2022 to be -$80,129,389, with the lowest OCGN earnings forecast at -$88,792,026, and the highest OCGN earnings forecast at -$67,135,434. On average, 4 Wall Street analysts forecast OCGN's earnings for 2023 to be -$84,460,707, with the lowest OCGN earnings forecast at -$110,448,617, and the highest OCGN earnings forecast at -$28,153,569.

In 2024, OCGN is forecast to generate -$73,632,411 in earnings, with the lowest earnings forecast at -$103,951,640 and the highest earnings forecast at -$41,147,524.

What is OCGN's revenue growth forecast for 2022-2024?

(NASDAQ: OCGN) Ocugen's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 23.83%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.53%.

Ocugen's revenue in 2022 is $0.On average, 1 Wall Street analysts forecast OCGN's revenue for 2022 to be $238,222,508, with the lowest OCGN revenue forecast at $238,222,508, and the highest OCGN revenue forecast at $238,222,508. On average, 1 Wall Street analysts forecast OCGN's revenue for 2023 to be $7,016,735,678, with the lowest OCGN revenue forecast at $7,016,735,678, and the highest OCGN revenue forecast at $7,016,735,678.

In 2024, OCGN is forecast to generate $12,749,235,475 in revenue, with the lowest revenue forecast at $6,548,953,300 and the highest revenue forecast at $18,949,517,650.

What is OCGN's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: OCGN) forecast ROA is 54.94%, which is higher than the forecast US Biotechnology industry average of 13.57%.

What is OCGN's Price Target?

According to 4 Wall Street analysts that have issued a 1 year OCGN price target, the average OCGN price target is $5.88, with the highest OCGN stock price forecast at $8.00 and the lowest OCGN stock price forecast at $4.50.

On average, Wall Street analysts predict that Ocugen's share price could reach $5.88 by Aug 23, 2023. The average Ocugen stock price prediction forecasts a potential upside of 219.29% from the current OCGN share price of $1.84.

What is OCGN's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: OCGN) Ocugen's current Earnings Per Share (EPS) is -$0.30. On average, analysts forecast that OCGN's EPS will be -$0.37 for 2022, with the lowest EPS forecast at -$0.41, and the highest EPS forecast at -$0.31. On average, analysts forecast that OCGN's EPS will be -$0.39 for 2023, with the lowest EPS forecast at -$0.51, and the highest EPS forecast at -$0.13. In 2024, OCGN's EPS is forecast to hit -$0.34 (min: -$0.48, max: -$0.19).

What is OCGN's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: OCGN) forecast ROE is 62.63%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.